Search company, investor...

Compare OcuNexus Therapeutics vs Lead Pharma

Customers evaluate the quality of OcuNexus Therapeutics's products using the following success metrics.

Overview

OcuNexus Therapeutics is 19 yrs old and is based in United States.

OcuNexus Therapeutics is a clinical-stage company focused on the healthcare sector, specifically in the development of treatments for diseases where the inflammasome pathway of inflammation is dysregulated. The company's main product is a small molecule, administered orally once a day, that targets the pathologically open Connexin43 Hemichannel, which is responsible for inflammasome mediated autoinflammation in several disease states. The company primarily sells to the ophthalmology and nephrology sectors, with a focus on conditions such as diabetic retinopathy, diabetic nephropathy, and the intermediate stage of macular degeneration. OcuNexus Therapeutics was formerly known as CoDa Therapeutics. It was founded in 2005 and is based in San Diego, California.

Lead Pharma Logo

Lead Pharma is based in Netherlands

Lead Pharma is a clinical-stage pharmaceutical research and development company, operating in the healthcare and pharmaceutical industry. The company's main focus is on designing and developing innovative small-molecule therapies, primarily aimed at treating autoimmune diseases and cancer. Lead Pharma primarily serves the healthcare sector, with a particular emphasis on the pharmaceutical industry. It is based in Oss, Netherlands.

Country

Netherlands

Demo Video

Demo not available because OcuNexus Therapeutics has not claimed their profile.

Work for OcuNexus Therapeutics? Show off your product.

Lead Pharma did not submit their demo in their Analyst Briefing

Work for Lead Pharma?

Leadership

Brian Levy (Chief Executive Officer)

See all 3 people

Frans van den Berg (Chief Executive Officer)

Funding

OcuNexus Therapeutics last raised $9.13M on 2/5/2021.
Lead Pharma last raised $11.86M on 11/17/2020.

Stage

Project Finance

Total Raised

Investors

GBS Venture Partners, Domain Associates

See all 4 investors

Product

Information not available because OcuNexus Therapeutics has not claimed their profile.

Work for OcuNexus Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for OcuNexus Therapeutics?

Claim your profile now.

Why Lead Pharma beats OcuNexus Therapeutics

    Benefits

    • Innovation
    • Technical experttise
    • Unique characteristics

    Products

    • Pipelines products in oncology or immunology

      Innovative new small molecule in oncology or immunology

    See all products

    Customers

    Lead Pharma did not submit their products in their Analyst Briefing

    Work for Lead Pharma?

    Known Partners

    Lead Pharma did not submit their partners in their Analyst Briefing

    Work for Lead Pharma?

    Why They Buy

    Lead Pharma did not submit their references in their Analyst Briefing

    Work for Lead Pharma?